Showing results (221-230 of 232) with videos related to
Sort By:
Pageof 24
The Lancet. Oncology|December 4, 2018
Consensus on molecular imaging and theranostics in prostate cancerStefano Fanti, Silvia Minozzi, Gerald Antoch, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 16, 2020
Optimum Imaging Strategies for Advanced Prostate Cancer: ASCO GuidelineEdouard J Trabulsi, R Bryan Rumble, Hossein Jadvar, et al.The Journal of Clinical Investigation|November 28, 2018
Single-dose radiotherapy disables tumor cell homologous recombination via ischemia/reperfusion injurySahra Bodo, Cécile Campagne, Tin Htwe Thin, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 8, 2018
Reproducibility and Repeatability of Semiquantitative 18F-Fluorodihydrotestosterone Uptake Metrics in Castration-Resistant Prostate Cancer Metastases: A Prospective Multicenter StudyHebert Alberto Vargas, Gem M Kramer, Andrew M Scott, et al.JAMA Oncology|December 28, 2018
Analysis of the Prevalence of Microsatellite Instability in Prostate Cancer and Response to Immune Checkpoint BlockadeWassim Abida, Michael L Cheng, Joshua Armenia, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 10, 2018
Multicenter Prospective Phase II Trial of Neoadjuvant Dose-Dense Gemcitabine Plus Cisplatin in Patients With Muscle-Invasive Bladder CancerGopa Iyer, Arjun V Balar, Matthew I Milowsky, et al.Nature Genetics|June 3, 2020
Unraveling tumor-immune heterogeneity in advanced ovarian cancer uncovers immunogenic effect of chemotherapyAlejandro Jiménez-Sánchez, Paulina Cybulska, Katherine LaVigne Mager, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 5, 2023
Multicenter Phase II Clinical Trial of Gemcitabine and Cisplatin as Neoadjuvant Chemotherapy for Patients With High-Grade Upper Tract Urothelial CarcinomaJonathan A Coleman, Wesley Yip, Nathan C Wong, et al.European Urology|September 26, 2025
Neoadjuvant Chemotherapy for High-risk Localized Upper Tract Urothelial Carcinoma: Final Long-term Outcomes from a Phase 2 Clinical Trial and an Expanded CohortViranda H Jayalath, Melissa Assel, Gopa Iyer, et al.JCO Precision Oncology|August 22, 2017
Prospective Genomic Profiling of Prostate Cancer Across Disease States Reveals Germline and Somatic Alterations That May Affect Clinical Decision MakingWassim Abida, Joshua Armenia, Anuradha Gopalan, et al.Pageof 24